Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Psychoneuroendocrinology. 2011 Sep 13;37(4):554–564. doi: 10.1016/j.psyneuen.2011.08.005

Table 1.

Demographic and clinical characteristics of the substance dependent (SD) and healthy control (HC) subjects

Subject Variable SD/HH (N=12) SD/HLLL (N=25) HC/HH (N=8) HC/HLLL (N=20)
Race
 Caucasian 4 (33.3%) 17 (68%) 6 (75%) 11 (55%)
 African American 6 (50%) 6(24%) 1(12.5%) 6(30%)
 Hispanic 0 2(8%) 1 (12.5%) 2 (10%)
 Other 2 (16.7%) 0 0 1 (5%)
Gender (Male) 7 (58.3%) 17 (68%) 6 (75%) 9 (45%)
Age * 37.6 (7.06) 37.6 (5.85) 34.8 (9.85) 29.1 (9.85)
Average Years of Education * 13.1 (1.78) 12.6 (1.23) 14.5 (1.97) 14.9 (1.77)
Average Years of Alcohol Use 12.4 (8.32) 13.7 (8.13) 8.9 (8.41) 7.5 (8.46)
Average Days of Alcohol Use/Month* 14.8 (9.04) 15.9 (11.97) 3.2 (3.35) 5.8 (8.33)
Total Amount (drinks) of Alcohol Use /Month* 187.7 (210.18) 242.3 (237.5) 8.0 (6.93) 11.5 (10.35)
Average Years of Cocaine Use 9.54 (4.72) 8.00 (7.26) - -
Average Days of Cocaine Use/Month 21.00 (10.43) 14.24 (13.23) - -
Total Amount (g) of Cocaine Use/Month 44.80 (38.22) 33.88 (23.14) - -
Average Days of Marijuana Use/Month 9.5 (12.94) 0.22 (0.52) - -
Total Amount (g) of Marijuana Use/Month 23.52 (26.60) 0.6 (0.94) - -
Regular Cigarette Smokers: N(%)* 8 (66.67%) 23 (92%) 4 (50%) 5 (25%)
Lifetime Prevalence of PTSD 2 (16.7%) 2 (8%) 0 2 (10%)
Lifetime Other Anxiety Disorders 3 (25%) 3 (12%) 0 0
Lifetime Major Depression 1 (8.3%) 7 (28%) 2 (25%) 1 (5%)

Note:

*

SD significantly different from HC group, p<0.05, but no differences between HH and HLLL groups; HH: NPY Diplotype predicting high NPY mRNA expression; HLLL: NPY diplotype predicting moderate and low NPY mRNA expression; PTSD: post-traumatic stress disorder